Kaken Pharmaceutical Co., Ltd. (president: Shiro Inui; Code No.: TSE First Section 4521) decided to increase the year-end dividend for the fiscal year ended March 2003 as shown below at a board meeting on April 24, 2003.
Kaken Pharmaceutical makes it its policy to return profits to its shareholders according to its business performance while building up an internal reserve sufficient for business development in the future. In accordance with this policy, its board of directors decided to propose the following increase in the year-end dividend at the 83rd regular shareholders’ meeting scheduled for the end of June 2003.
|Mid-year dividend||Year-end dividend||Annual dividend|
|Earlier forecast made on November 21, 2002||¥3.75||¥3.75||¥7.50|
|Dividend per share in the previous fiscal year||¥3.75||¥3.75||¥7.50|